Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?

Phillip A. Low; Sid Gilman

doi:10.1002/ana.23655

Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?

Phillip A. Low, Sid Gilman

Neurology

Research output: Contribution to journal › Editorial › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	4-5
Number of pages	2
Journal	Annals of neurology
Volume	72
Issue number	1
DOIs	https://doi.org/10.1002/ana.23655
State	Published - Jul 2012

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1002/ana.23655

Cite this

@article{a799410b095d46018c7a2798fecf47ec,

title = "Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?",

author = "Low, {Phillip A.} and Sid Gilman",

year = "2012",

month = jul,

doi = "10.1002/ana.23655",

language = "English (US)",

volume = "72",

pages = "4--5",

journal = "Annals of neurology",

issn = "0364-5134",